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Although less well-recognized than for other infectious diseases, heterogeneity is a defining feature of tuberculosis (TB) epidemiol-
ogy. To advance toward TB elimination, this heterogeneity must be better understood and addressed. Drivers of heterogeneity in TB 
epidemiology act at the level of the infectious host, organism, susceptible host, environment, and distal determinants. These effects 
may be amplified by social mixing patterns, while the variable latent period between infection and disease may mask heterogeneity in 
transmission. Reliance on notified cases may lead to misidentification of the most affected groups, as case detection is often poorest 
where prevalence is highest. Assuming that average rates apply across diverse groups and ignoring the effects of cohort selection 
may result in misunderstanding of the epidemic and the anticipated effects of control measures. Given this substantial heterogeneity, 
interventions targeting high-risk groups based on location, social determinants, or comorbidities could improve efficiency, but raise 
ethical and equity considerations.
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Although estimates of the global burden of tuberculosis (TB) sug-
gest gradual decline, this aggregate profile masks a patchy, het-
erogeneous epidemic that predominantly afflicts society’s most 
marginalized groups. Meanwhile, the causative organism is now 
the world’s leading infectious killer and dramatic reductions in 
burden will be necessary if the bold new End TB targets are to 
be realised [1]. Heterogeneity in disease distribution increases as 
the burden of an infectious disease declines and becomes more 
unevenly distributed across space or social networks [2]—a phe-
nomenon that is well recognized in the case of diseases such as 
malaria [3]. There are many reasons to suspect that TB epidemics 
are highly heterogeneous, such as the prominence of highly local-
ized or household transmission, the wide geographical variation in 
disease burden within and between countries, and the many indi-
vidual-level factors strongly associated with risk of disease. Here 
we describe key drivers of heterogeneity in TB burden, discuss the 
challenges in quantifying this heterogeneity, and consider implica-
tions for transmission dynamics and the design of interventions.
DRIVERS OF HETEROGENEITY
Risk of infectious disease is dependent on characteristics of the 
infectious host, the organism, the susceptible host, and the envi-
ronment (Figure 1; Table 1). The complex interplay between the 
pathogen and the host’s immune system and the propensity for 
Mycobacterium tuberculosis (Mtb) to enter a latent state following 
infection mean that many exposed individuals will never prog-
ress to active TB disease. Therefore, individual characteristics 
that predispose to susceptibility to infection, progression to dis-
ease after infection, and infectiousness during disease episodes 
all contribute to heterogeneity, although the risk factors associ-
ated with each differ considerably. For example, risk of exposure 
is driven by sociodemographic factors (eg, crowding, contact 
patterns), susceptibility to infection once exposed is influenced 
by processes that impair local immune responses (eg, smoking), 
progression to disease may reflect systemic immune status (eg, 
human immunodeficiency virus [HIV], nutrition), and likeli-
hood of onward transmission may be altered by cough symptom-
atology and disease duration (eg, through access to care).
The Infectious Host
Medical and demographic factors also strongly influence the 
extent to which each affected person propagates Mtb infec-
tion. Smear-positive adults and particularly those with cavi-
tary pulmonary TB transmit infection more extensively [13], 
while many others, such as those with only extrapulmonary 
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involvement, may infect no one. Although children and persons 
with HIV are less likely to transmit, the degree of infectiousness 
is variable, with children aged >10 years more often manifest-
ing adult forms of TB [14, 15]. Despite its limitations, smear 
microscopy remains the mainstay of TB diagnosis worldwide 
with advantages that include its ability to identify highly infec-
tious individuals. Social factors such as mixing patterns also 
influence spread by modifying the number of contacts exposed 
and these patterns also differ by setting (eg, household, work-
place, general community). Importantly, social mixing patterns 
may act differently for Mtb than for other infections, given that 
Mtb, unlike many other major pathogens, is airborne and so can 
be transmitted without the need for direct person-to-person 
contact. However, the rate of transmission per day infectious 
is considerably lower than for other respiratory pathogens (eg, 
measles, influenza) [16], meaning that amplifying factors such 
as cough characteristics, ability to generate aerosols of appro-
priate size [17], and environmental factors may strongly influ-
ence whether infection occurs. Finally, myriad programmatic 
and social factors delay diagnosis and so prolong the infectious 
period and increase the duration of exposure [18], thereby 
potentiating heterogeneity through their impact on the most 
marginalized groups.
The Infecting Organism
Mtb is a clonal pathogen that displays variable fitness and a com-
plex interaction with its human host [19]. Its multiple lineages 
differ in their genomic makeup and in several aspects of their 
clinical and epidemiological behavior, including disease pro-
gression, disease severity, transmissibility, and geographic dis-
tribution (Supplementary Bibliography). With recent advances 
in molecular epidemiology, the influence of Mtb genetic diver-
sity on the outcomes of TB infection and disease is increasingly 
recognized. Strains are thought to have adapted to the human 
population they affect [20], resulting in a sympatric relationship 
whereby co-evolved host populations show high rates of TB due 
to certain strains, but concentration within high-risk groups 
elsewhere [21]. However, the discordance in findings between 
settings and the complex interaction between pathogen, host, 
and environment remain challenges to understanding these 
processes.
Arguably, the most critical form of pathogen-related heteroge-
neity is drug resistance, which makes clinical management con-
siderably more challenging and expensive. Epidemiologically, 
transmission cycles of drug-resistant TB (DR-TB) differ from 
those of drug-susceptible TB because of limited access to the 
diagnostics available for determining drug resistance, the long 
duration of DR-TB treatment, and clustering of DR-TB patients 
in high-risk settings. All of these factors may act to prolong the 
infectious period, sustaining transmission chains of DR-TB 
[22]. Resistance-conferring mutations may be offset by associ-
ated physiological impairments in the organism that limit its 
ability to survive and reproduce (“fitness costs”), although sus-
tained drug exposure may select for bacteria with compensa-
tory mutations [23]. Moreover, fitness costs are likely to vary 
according to the drug in question (eg, higher for rifampicin 
resistance than for isoniazid or streptomycin) [24], while both 
modeling studies and large-scale outbreaks highlight the poten-
tial for DR-TB to proliferate [25].
The Susceptible Host
Characteristics of the susceptible host also markedly influ-
ence the likelihood of disease following exposure, which may 
reflect both susceptibility to infection or greater risk of pro-
gression to disease for those infected. Patterns of reactiva-
tion differ markedly by age, and comorbidities such as HIV, 
poverty
equity
employment
Figure 1. Conceptual framework for understanding heterogeneity in tuberculosis 
epidemiology. The cone indicates that the most local drivers are positioned toward 
the top of the figure and the broadest drivers toward the bottom, rather than reflect-
ing the importance of these factors.
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diabetes, malnutrition, and heavy alcohol use are critical 
considerations in the variation of risk of disease progression 
observed (Supplementary Bibliography). For example, HIV is 
the strongest individual-level risk factor and a major driver of 
the TB epidemic in many parts of Africa, while the rising global 
prevalence of noncommunicable diseases (eg, diabetes) may 
hinder our ability to achieve control targets by impairing host 
immunity at the population level [26]. History of exposure and 
disease are also important, as people who are latently infected 
may have partial protection against reinfection with the patho-
gen [27], whereas previously treated persons are likely to be 
at substantially increased risk for recurrent disease [28]. This 
latter increase in risk may reflect repeated exposure, incomplete 
treatment, or underlying immunological vulnerability [29].
The Physical Environment
The setting in which TB is transmitted is also an important 
modifier of spread—either due to increased population density 
or congregation of individuals with higher rates of specific risk 
factors, or directly through environmental features that facili-
tate airborne transmission. Characteristics of the physical envi-
ronment that may contribute to transmission include crowding, 
poor ventilation, and high levels of indoor air pollution [30]. 
Furthermore, locations with these characteristics (eg, clinics, 
Table 1. Examples of Specific Forms of Heterogeneity and Ways Forward
Source of  
Heterogeneity Examples of Existing Evidence Data Needs Analytic Needs Intervention Needs
Infectious host Sequencing and social network 
analysis suggest that some 
individuals may act as 
“superspreaders” [4]
Importance of biological 
variables, eg, 
aerosolization, cough 
frequency
Implications of hosts with 
differential infectiousness 
and superspreading
Tools to identify the most 
infectious patients
Available data on contact 
patterns (principally from low-
burden settings) suggest age-
specific (assortative) mixing
Data on contact patterns 
from high-burden settings 
and for risk factors 
relevant to TB (eg, HIV 
status)
Importance of population 
groups to sustaining 
transmission relative to 
their burden of disease
Case-finding efforts designed to 
identify patients with high-risk 
mixing patterns for broader 
dissemination of infection
Infecting organism Strain responsible for extensive 
community spread confirmed 
to be highly virulent in mouse 
model [5]
Mechanisms of strain 
diversity and virulence
Implications of selecting for 
strains of greater fitness
Interventions to limit 
infectiousness of difficult-to-
treat strains
Highly resistant forms of TB 
causing extensive outbreaks, 
eg, XDR-TB in Tugela Ferry, 
South Africa [6]
Fitness costs associated 
with drug resistance
Likely future trajectory of 
drug resistance
Improved identification 
and treatment of highly 
transmissible strains of drug-
resistant TB
Susceptible host Individuals previously treated 
for TB had higher rates 
of recurrent TB due to 
reinfection than the general 
population in Cape Town, 
South Africa [7]
Protection or susceptibility 
afforded by past TB 
episodes and whether 
this is attributable to 
infection or progression 
risk
Distinguish the individual-
level effect of increased 
susceptibility post–disease 
episode from the effect 
of selecting for a more 
susceptible cohort through 
infection
Protection of highest-risk 
individuals from infection or 
progression to disease
Specific risk groups may 
experience polyclonal 
outbreaks [8]
Better estimates of disease 
prevalence in risk groups
Anticipated effects of trends 
in comorbid risk factors 
on TB
TB control interventions that link 
with systems for other high-
risk conditions
Physical environment Incarceration may have been 
a significant driver of 
community transmission [9]
Better estimates of location-
specific TB transmission 
risk
Valid models for translating 
environmental 
heterogeneity into 
transmission risk
Active case finding targeted at 
high-risk environments (eg, 
prisons, transit)
Greater proportion of infected 
contacts in less well-
ventilated hospital wards [10]
Ability of specific 
interventions (eg, 
improved ventilation) to 
reduce that risk
Projected population-level 
impact of targeted 
environmental 
interventions
Mitigation of TB transmission 
through modification of high-
risk built environments
Distal determinants Ecological observation of 
declining TB rates during 
times of improvements in 
living standards [11]
Mechanistic linkages 
between poverty 
alleviation and TB 
transmission
Projected ability of social 
protection and similar 
efforts to reduce 
heterogeneity
Linkage between TB control 
programs and schemes 
to alleviate poverty and/
or address other distal 
determinants
Association between coverage 
of Brazil’s conditional cash 
transfer program and 
improved TB control [12]
TB-specific effects of 
broader interventions
Models of the impact of 
TB on other outcomes in 
vulnerable populations
Implementation of TB 
interventions in a fashion 
that mitigates burden on the 
highest-risk populations, thus 
promoting equity and reducing 
disparities in risk
Abbreviations: HIV, human immunodeficiency virus; TB, tuberculosis; XDR-TB, extensively drug-resistant tuberculosis.
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public transit, churches, prisons, mines, and informal drinking 
spaces) are often frequented by the same high-risk individuals, 
further fueling heterogeneous transmission in these sites. These 
locations are themselves likely to be in close proximity, enhanc-
ing transmission in impoverished areas [31] and sustaining the 
epidemic [32].
Structural and Social Determinants
Heterogeneity at the community level is driven by a complex 
network of proximal and distal determinants that may not al-
ways be fully explained by quantifiable risk factors. Migration, 
urbanization, demographic transition, and other broad global 
trends combined with weak and inequitable policy and pla-
nning lead to pockets of poverty, unhealthy behaviors, and 
weak health systems in which TB thrives [33]. Social or spa-
tial clustering of the individual-level characteristics described 
in the preceding sections may magnify the effect of these risk 
factors through transmission, as persons contact one another 
more if they share similar characteristics (assortative mixing). 
However, understanding of the effect of the various upstream 
determinants responsible for driving heterogeneity in TB 
burden is limited by the relative paucity of modeling studies 
in this area [34].
CHALLENGES IN QUANTIFYING HETEROGENEITY
Although substantial between- and within-country differ-
ences in burden are frequently reported, challenges exist in 
interpreting the differences observed between demographic, 
geographical, or other subdivisions of the population. Our 
understanding of the population-level epidemiology of TB 
disease relies to a large extent on cases that have sought care, 
received a diagnosis, and been recorded through surveillance 
systems or local studies. The substantial proportion of cases 
that does not reach this stage in many settings [1] means that 
our estimates of heterogeneity in burden are prone to bias 
(Figure  2A and 2B). A  particular consequence of relying on 
data from detected cases arises from the negative correlation 
between TB burden and access to care, which may mask heter-
ogeneity in disease. For example, TB prevalence surveys con-
sistently show a male predominance among adult TB cases, but 
this gender gap is much smaller in notifications—suggesting 
that men experience a higher burden but seek or access care 
at a lower rate than women [35]. Similar and even stronger 
unobserved effects, whereby mechanisms that increase risk of 
TB also decrease the probability of detection, may exist for fea-
tures such as socioeconomic status or locality. Moreover, even 
if bias could be eliminated from health information systems, 
routinely collected data are not typically disaggregated beyond 
broad age categories, geographic regions, and drug resistance 
profiles, thereby limiting our ability to observe heterogeneity 
between smaller subpopulations without specifically designed 
studies.
Much less biased measures of disease burden are avail-
able from the recent increase in TB prevalence surveys. 
However, prevalence surveys in the general population are 
expensive undertakings and typically designed to yield a rel-
ative precision of 20%–25% [36], limiting their ability to dis-
cern patterns among subgroups or at the district/local level. 
Moreover, prevalence surveys are by design cross-sectional, 
meaning that they cannot provide information on hetero-
geneity through time without additional assumptions or re-
peated data collection.
One important consequence of detection bias is that clusters 
of notifications are difficult to interpret. Apparent hotspots of 
TB disease may represent either true areas of intense transmis-
sion or better diagnosis (via targeted campaigns or differential 
access to care), such that the areas of most intense transmis-
sion may be those with the highest notification rates in some 
settings and the lowest in others. Travel to access care may fur-
ther exaggerate this process, creating artefactual aggregations of 
notifications. By contrast, heterogeneity in transmission may be 
masked by the often substantial latent period between infection 
and disease onset, during which infected individuals may relo-
cate (Figure 2C and 2D). This process smooths disease distribu-
tion and obscures transmission chains, while the distribution of 
transmission and latent infection are even harder to observe in 
Figure  2. Illustration of some selected concepts from the text. A, Degree of 
heterogeneity that might be observed among individuals with good access to the 
healthcare system (unblurred discs) compared to those with poor access (blurred 
discs). This may be substantially less than the heterogeneity that exists in the pop-
ulation as a whole (B). C, Series of transmission events. D, Subsequent relocation 
of infected and uninfected individuals. This results in a more homogeneous dis-
tribution of infection across the population at this later time point, even though 
transmission was highly heterogeneous. E, Series of individuals at variable risk 
of infection. F, Selection of higher-risk individuals through the infection process. 
Although infection is the selecting illustrated process here, similar principles would 
apply to progression from infection to disease, through stages of the disease pro-
cess and to interaction with the health system. Abbreviation: TB, tuberculosis.
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an era when population-wide surveys of infection are no longer 
undertaken.
IMPLICATIONS FOR UNDERSTANDING AND 
MODELING TRANSMISSION
The impact of heterogeneity of infectiousness is influenced by 
characteristics of the infectious host and the organism being 
transmitted, and can be explored through its specific effects on 
the basic reproduction number, R0 [37]. While the point esti-
mate of R0 is often emphasized as a measure of the expected 
number of secondary cases caused by an average index case in 
an infection-naive population, infectiousness may more appro-
priately be viewed as a probability distribution across a popu-
lation of individuals, each with their own expected number of 
secondary cases. While superspreading is clearly observable in 
TB genomic studies [38], saturation of close contacts, whereby 
contacts occur primarily among individuals who have already 
been infected, may increase the importance of community 
transmission in high-burden settings [39].
When heterogeneity in susceptibility to TB exists, concerns 
regarding the assumption of a homogeneous population parallel 
concepts familiar in noncommunicable diseases, such as cohort 
selection and frailty models in survival analysis. As higher-risk 
individuals develop incident disease [28, 40], the incidence 
rate of a cohort may decline simply because those who remain 
susceptible have a lower average risk (Figure 2E and 2F). This 
process is disabled in models that collapse risk distributions to 
their mean values, leading to inaccurate simulations and biased 
predictions. Population-level heterogeneity in susceptibility 
can also induce thresholds near which small epidemiological 
changes will cause dramatic shifts in disease burden, leading to 
unanticipated effects of preventive interventions [41] and faster 
emergence of drug-resistant strains [42].
Any transition rate can be affected by cohort selection, as 
illustrated in Figure 3. Instead of the disease incidence process 
discussed above, consider a cohort of individuals with active TB 
comprised of 2 groups: fast and slow care seekers. As the faster 
care seekers leave the cohort earlier, the overall care-seeking 
rate will decline over time, even though it remains constant in 
each group. This process complicates estimation procedures and 
can be especially problematic in relation to rates of infection, 
which are proportional to the prevalence of infectious individ-
uals and so part of a feedback loop. Moreover, epidemiological 
uncertainty around the most appropriate parameter values for 
transmission models means that multiple parameter sets may 
superficially replicate observed burden [43], which is particu-
larly problematic for an endemic infection with a prolonged and 
unpredictable latency period.
IMPLICATIONS FOR CONTROL
Targeting Risk Groups
A consequence of the heterogeneity in transmission, infection, 
incidence, and mortality is that benefits of interventions will dif-
fer depending on the groups targeted and the distribution of the 
risk factors introduced above. This consideration motivates much 
current TB policy, with groups at higher risk of infection, disease, 
or poor outcomes from TB episodes, such as household contacts, 
children, persons living with HIV, individuals with end-stage 
renal disease, and previously treated people identified as high-pri-
ority groups for screening and treatment of latent and active TB 
(Supplementary Bibliography). Heterogeneity in historical TB 
exposure is also a focus of interventions, with many low-incidence 
countries targeting services to foreign-born individuals [44], 
given their higher prevalence of latent TB and consequent risk of 
reactivation. However, interventions targeted at high-risk popu-
lations have not always been successful: A trial of mass screening 
and preventive treatment in South African miners had no impact 
on TB rates [45], because of reactivation of noncured infections 
and reinfection in the context of insufficient treatment and ongo-
ing high environmental transmission risk [46].
Synergies With Non-TB Interventions
Regular interactions with the healthcare system for the man-
agement of chronic and noncommunicable diseases offer the 
opportunity for intensified case finding efforts, given that many 
such conditions increase TB risk or co-occur in populations 
Figure  3. Composition of a simple 2-stratum heterogeneous cohort over time 
from entry to an epidemiological state (active undiagnosed tuberculosis). Plot dis-
plays the percentage of patients with active tuberculosis remaining undiagnosed 
after the onset of infectiousness (time 0 on the horizontal axis), under the assump-
tion that 50% of the initial cohort has an average duration of infectiousness of 
1 month (high-rate group), and 50% of the cohort has a duration of infectiousness 
of 6 months (low-rate group). The true total percentage of patients remaining infec-
tious with time since onset of infectiousness (solid line) is compared against the 
proportion that would be expected to remain if the whole cohort was assumed to 
have the average time to diagnosis (3.5 months), and the proportion that would be 
expected to remain if the whole cohort was assumed to have a rate of diagnosis 
that is the average of the rates of the 2 groups (dotted line). The amount of the total 
population comprised of high-rate and low-rate persons at each time point is indi-
cated by colored shading, demonstrating that the remaining cohort is increasingly 
comprised of low-rate individuals over time.
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with such increased risk. More broadly, strengthening health 
systems for both TB and noncommunicable disease control pro-
vides the potential for synergistic interventions across diseases 
[47], while improving control by addressing distal determinants 
should also be a high priority [48]. The observation that both 
historical and more recent declines [11, 33] in TB burden have 
usually been achieved in the context of improvements in so-
cioeconomic indicators highlights the importance of such up-
stream determinants and is particularly relevant in the era of 
the United Nations Sustainable Development Goals.
Geographical Targeting
TB incidence shows considerable geographical clustering at multi-
ple resolutions [49], and spatial targeting of interventions has the 
potential to achieve major reductions in burden through focus-
ing on geographically discernible TB hotspots [50]. However, the 
extent of mixing between hotspots and the broader population is 
important to quantify as it will modify the impact of such inter-
ventions [51]. Intensive TB control interventions targeted at Inuit 
communities in northern Canada, Alaska, and Greenland were 
effective at substantially reducing the extreme rates of TB incidence 
and mortality observed in the 1950s [52]. New and emerging ana-
lytic tools offer opportunities to identify and quantify TB hotspots, 
such as a recent genomic analysis in Peru that highlighted the spa-
tial aggregation of multidrug-resistant genotypes [32].
Effect of Interventions on Heterogeneity
Where substantial reductions in TB burden are achieved, het-
erogeneity in TB distribution may increase, as transmission 
becomes more localized to remaining regions and population 
groups with fewer resources, limited healthcare access, and 
insufficient adherence to policy. However, even when fully 
implemented, control efforts may increase or decrease trans-
mission heterogeneity depending on the intervention design. 
Interventions directed at those with poor access to care and 
thus high burden of disease may reduce heterogeneity, whereas 
interventions that strengthen routine programmatic manage-
ment may increase heterogeneity even while decreasing overall 
burden. Heterogeneity may modify the impact of both targeted 
and untargeted interventions depending on the background 
burden of disease. For example, successful detection and treat-
ment of a single active case may eliminate transmission from 
a community in a low-burden setting, whereas this would be 
harder to achieve in a high-burden setting. This may lead to 
unexpected relationships between control efforts and conse-
quent reduction in the annual risk of Mtb infection [53].
Economic and Equity Concerns
The targeting of TB control interventions to those with high 
rates of infection or disease is expected to increase the effec-
tiveness of interventions. Consequent gains in efficiency will 
depend on coverage levels, accessibility, disease prevalence, and 
contribution to transmission in the wider population of the 
target group. There are economies of scale to be achieved when 
increasing coverage, yet at high levels of coverage or for diffi-
cult-to-reach populations, targeted strategies may require addi-
tional supporting activities and so increase resource needs. For 
example, the cost-effectiveness of active case finding strategies 
is driven by both the heterogeneity in disease rates and in the 
cost of reaching different subgroups [54]. While maximizing 
impact within a given budget is a key objective in priority set-
ting, heterogeneity in burden, healthcare access, and financial 
resources are linked to equity concerns in resource allocation 
for TB control strategies. Conceptually, the difference between 
inequalities and inequities is a value judgement about whether 
the observed heterogeneity is considered fair. Policy makers 
should seek to ensure that populations already experiencing 
increases in risk due to socioeconomic or other conditions (eg, 
crowding, incarceration) do not experience additional dispari-
ties in access to TB diagnosis and treatment, financial burden of 
illness, or unwarranted exposure to infection. While the reduc-
tion of such disparities is a key policy objective, there are situ-
ations in which achieving it may imply trade-offs in efficiency 
gains. For example, interventions aiming to place new technol-
ogies at decentralized locations may not be as cost-effective as 
placement at higher levels of the health system, yet may still 
be prioritized to reduce social inequities in financial burden, 
health outcomes, and access to health services [55].
WAYS FORWARD AND CONCLUSIONS
Causes of heterogeneity in TB epidemiology are diverse and 
include characteristics of the infectious host, pathogen, suscepti-
ble host, environment, and distal determinants—factors that may 
interact to amplify or reduce heterogeneity. Observed heteroge-
neity may not reflect reality and targeted epidemiological studies 
to quantify disease burden in more detail would be valuable, for 
example, prevalence surveys powered to obtain precise estimates of 
disease burden in specific population risk groups and age groups.
All TB modeling studies must judge which aspects of het-
erogeneity are sufficiently important to include given the ques-
tion posed and the local context, and those which should not 
be specifically incorporated for parsimony. This highlights the 
importance of (1) detailed, context-specific data; (2) refining 
parameter estimation through epidemiological research; (3) 
communicating uncertainty in predictive modeling; and (4) 
confirmation of the predicted effectiveness and cost of inter-
ventions through operational research.
Heterogeneity has implications for the effectiveness and ef-
ficiency of control interventions. Targeting of interventions is 
an appropriate consideration in designing intervention strate-
gies, although evidence to support specific targeted approaches 
is sometimes weak or contradictory. Therefore, such strategies 
must be considered in the context of resource availability and 
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the ethical imperative to ensure universal access to high-quality 
care. Moreover, it is also important to balance the need for clear 
guidelines that can facilitate the broad implementation of inter-
ventions at a national or global level against the importance of 
developing interventions that are targeted toward specific char-
acteristics of regional or local epidemics.
As the global TB control community looks toward ending 
TB, understanding and harnessing heterogeneity to improve 
control will become increasingly important. Key considerations 
in addressing heterogeneity include better assessment of disease 
burden in population subgroups, context-specific modeling, 
targeting of interventions, and a focus on distal determinants of 
inequities in health status.
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